FINWIRES · TerminalLIVE
FINWIRES

CorMedix Says Rezzayo Met Primary Endpoint in Study of Prevention of Invasive Fungal Diseases

By

-- CorMedix Therapeutics (CRMD) said Monday that a phase 3 trial evaluating Rezzayo for the prevention of invasive fungal diseases in stem cell transplant patients met its primary endpoint.

The trial met the primary endpoint of 60.7% fungal-free survival at day 90 compared to 59.0% for the standard antimicrobial regimen, the company said.

Rezzayo, or rezafungin for injection, was well tolerated with a safety profile showing a favorable benefit-risk profile for immunocompromised patients, CorMedix said.

Shares of CorMedix were up 2.3% in Monday trading.

Price: $7.67, Change: $+0.25, Percent Change: +3.37%

Related Articles

Australia

Capitol Federal Financial Maintains Quarterly Dividend

Capitol Federal Financial (CFFN) said Tuesday it maintained its quarterly dividend at $0.085 per share, payable May 15 to stockholders of record May 1.The company repurchased nearly 3.1 million common shares at an average cost of $7.27 apiece from Jan. 1 to April 22, 2026, according to a statement.The company said it will release financial results for the quarter ended March 31 on April 29.Price: $7.86, Change: $-0.02, Percent Change: -0.32%

$CFFN
Insider Trading

Union Pacific Insider Sold Shares Worth $7,442,691, According to a Recent SEC Filing

Kenyatta G Rocker, Executive Vice President, Marketing and Sales, on April 24, 2026, sold 27,387 shares in Union Pacific (UNP) for $7,442,691. Following the Form 4 filing with the SEC, Rocker has control over a total of 64,792 common shares of the company, with 61,102 shares held directly and 3,690 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/100885/000010088526000158/xslF345X05/edgardoc.xmlPrice: $268.39, Change: $-0.52, Percent Change: -0.19%

$UNP
Insider Trading

Union Pacific Insider Sold Shares Worth $549,400, According to a Recent SEC Filing

Jennifer L Hamann, Chief Financial Officer & Executive Vice President, on April 24, 2026, sold 2,000 shares in Union Pacific (UNP) for $549,400. Following the Form 4 filing with the SEC, Hamann has control over a total of 120,329 common shares of the company, with 114,642 shares held directly and 5,687 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/100885/000010088526000159/xslF345X05/edgardoc.xmlPrice: $268.52, Change: $-0.39, Percent Change: -0.15%

$UNP